arrow
J

Jason Roszik

The University of Texas MD Anderson Cancer Center
H指数:56
被引数:2.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phase I study of sapanisertib with carboplatin and paclitaxel in mTOR pathway altered solid malignancies
2023-04-182
OAAI
BRAF v600E-mutant cancers treated with vemurafenib alone or in combination with everolimus, sorafenib, or crizotinib or with paclitaxel and carboplatin (VEM-PLUS) study

单独使用维罗非尼或与依维莫司,索拉非尼或克唑替尼或紫杉醇和卡铂联合治疗的BRAF v600E-mutant癌症 (vem-plus) 研究

2023-02-186
OAAI
Charge-based interactions through peptide position 4 drive diversity of antigen presentation by human leukocyte antigen class I molecules

通过肽位置4的基于电荷的相互作用驱动人类白细胞抗原I类分子的抗原呈递的多样性

2022-07-273
OAAI